KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Cash from Operations (2016 - 2026)

Amgen has reported Cash from Operations over the past 18 years, most recently at 2189000000.0 for Q1 2026.

  • For Q1 2026, Cash from Operations rose 57.37% year-over-year to 2189000000.0; the TTM value through Mar 2026 reached 10756000000.0, down 11.78%, while the annual FY2025 figure was 9958000000.0, 13.33% down from the prior year.
  • Cash from Operations for Q1 2026 was 2189000000.0 at Amgen, up from 1603000000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 4771000000.0 in Q4 2024 and troughed at 538000000.0 in Q4 2023.
  • A 5-year average of 2460529411.76 and a median of 2280000000.0 in 2025 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: crashed 79.69% in 2023 and later skyrocketed 786.8% in 2024.
  • Year by year, Cash from Operations stood at 2649000000.0 in 2022, then crashed by 79.69% to 538000000.0 in 2023, then skyrocketed by 786.8% to 4771000000.0 in 2024, then crashed by 66.4% to 1603000000.0 in 2025, then soared by 36.56% to 2189000000.0 in 2026.
  • Business Quant data shows Cash from Operations for AMGN at 2189000000.0 in Q1 2026, 1603000000.0 in Q4 2025, and 4684000000.0 in Q3 2025.